A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients

Clinical trial NCT01594541 · UNKNOWN

Trial details

NCT number: NCT01594541
Sponsor: Pamlab, Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Mild Cognitive Impairment

Start date: 2013-01-01
Primary completion: 2013-08-01
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.